Due to the excellent feedback received on our Cell & Gene Therapy Best Practices rollout, we’re hosting two webinar sessions for you to call in, hear more about the details and ask questions. Representatives from both Tokio Marine HCC - Stop Loss Group (TMHCC) and Emerging Therapy Solutions (ETS) will be on the call.
We are offering two sessions for the training. Please use one of the links below to sign up. After you register, you will receive an email confirmation with details on how to join the webinar.
TMHCC is a leading provider of medical stop loss coverage provided through brokers, consultants and third-party administrators. By listening to the demands of the market, we have developed exceptional products, unparalleled resources and value-added services that set us apart in the industry. Visit our website to learn more about our innovative stop loss, Taft-Hartley, captive and organ transplant solutions.